Rocket Pharmaceuticals (RCKT)
(Delayed Data from NSDQ)
$21.98 USD
-0.12 (-0.54%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $21.97 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.69 |
EPS Last Quarter | -0.64 |
Last EPS Surprise | 20.00% |
ABR | 1.21 |
Earnings ESP
|
-6.99% |
---|---|
Current Year | -2.94 |
Next Year | -1.91 |
EPS (TTM) | -2.94 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 9.68M | 26.93M | 184.34M |
# of Estimates | NA | 2 | 5 | 5 |
High Estimate | NA | 18.36M | 103.86M | 325.80M |
Low Estimate | NA | 0.99M | 0.80M | 23.10M |
Year ago Sales | 0.00M | 0.00M | NA | 26.93M |
Year over Year Growth Est. | NA | NA | NA | 584.56% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.69 | -0.69 | -2.94 | -1.91 |
# of Estimates | 6 | 5 | 8 | 6 |
Most Recent Consensus | -0.70 | -0.72 | -3.26 | -1.35 |
High Estimate | -0.50 | -0.49 | -1.95 | -0.50 |
Low Estimate | -0.83 | -0.85 | -3.38 | -3.17 |
Year ago EPS | -0.73 | -0.82 | -2.92 | -2.94 |
Year over Year Growth Est. | 5.48% | 15.85% | -0.68% | 35.14% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 4 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 0 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.69 | -0.69 | -2.94 | -1.91 |
7 Days Ago | -0.69 | -0.69 | -2.94 | -1.91 |
30 Days Ago | -0.69 | -0.69 | -2.94 | -1.91 |
60 Days Ago | -0.69 | -0.69 | -3.00 | -1.90 |
90 Days Ago | -0.71 | -0.71 | -2.97 | -1.75 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.74 | -0.69 | -3.11 | -2.62 |
Zacks Consensus Estimate | -0.69 | -0.69 | -2.94 | -1.91 |
Earnings ESP | -6.99% | 0.00% | -5.74% | -37.30% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.64 | -0.75 | -0.82 | -0.73 | NA |
Estimate | -0.80 | -0.82 | -0.80 | -0.86 | NA |
Difference | 0.16 | 0.07 | -0.02 | 0.13 | 0.09 |
Surprise | 20.00% | 8.54% | -2.50% | 15.12% | 10.29% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more